TCT 2015: Heartflow’s FFR CT Could Bring Costs Down By One-Third
This article was originally published in Clinica
Executive Summary
HeartFlow’s FFR CT imaging system has demonstrated that it can pare off over 30% of the average cost of treating symptomatic patients at intermediate risk of coronary disease, while improving their quality of life. Experts who have reviewed the data from a cost and quality-of-life analysis of the PLATFORM trial caution, however, that this result will have to be confirmed in large randomized trials before FFR CT imaging supplants other types of noninvasive testing.